Australia markets closed

PharmaRoth Labs, Inc. (ROTH)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 11:34AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.42M
Enterprise value 1.42M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.37
Price/book (mrq)N/A
Enterprise value/revenue 7.09
Enterprise value/EBITDA -3.74

Trading information

Stock price history

Beta (5Y monthly) -1.90
52-week change 3-95.00%
S&P500 52-week change 325.59%
52-week high 30.0001
52-week low 30.0000
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 346.38k
Avg vol (10-day) 335.63k
Shares outstanding 5149.35M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 25:1
Last split date 301 June 2010

Financial highlights

Fiscal year

Fiscal year ends 30 June 2010
Most-recent quarter (mrq)31 Mar 2011

Profitability

Profit margin -278.60%
Operating margin (ttm)-49.09%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)200.15k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-557.63k
Diluted EPS (ttm)-0.0040
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)33
Total cash per share (mrq)0
Total debt (mrq)250k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.24
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-170.46k
Levered free cash flow (ttm)N/A